SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-286378
Filing Date
2020-11-05
Accepted
2020-11-05 09:20:02
Documents
15
Period of Report
2020-11-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d16187d8k.htm   iXBRL 8-K 28735
2 EX-1.1 d16187dex11.htm EX-1.1 165897
3 EX-5.1 d16187dex51.htm EX-5.1 9521
7 GRAPHIC g161872.jpg GRAPHIC 4639
  Complete submission text file 0001193125-20-286378.txt   391824

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20201105.xsd EX-101.SCH 3087
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20201105_lab.xml EX-101.LAB 18907
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20201105_pre.xml EX-101.PRE 11874
8 EXTRACTED XBRL INSTANCE DOCUMENT d16187d8k_htm.xml XML 3514
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 201289045
SIC: 2834 Pharmaceutical Preparations